*Corresponding author:Cecchini F, Turval Laboratories Ltd, Head Office and Research Department Scientific and Technological Park, Italy
Received: November 23, 2018; Published: December 11, 2018
To view the Full Article Peer-reviewed Article PDF
Halitosis (oral malodour) is a common problem, which creates severe social and relational difficulties. The most popular approach is to mask the smell, without considering the bacterial aetiology of the problem. The aim of this study is to demonstrate the efficacy of the administration of encapsulated Kluyveromyces marxianus B0399 by measuring the amount of VSC (Volatile Sulphur Compounds) with follow-up at 7 and 14 days. At the end of treatment, about 91% of patients did not present halitosis. The protocol did not consider any oral hygiene treatment. The drug is in capsule form with a shell. Therefore, results were achieved with a direct action on the intestine, not at an oral level. In conclusion, this study proves that, besides the rebalancing effect of probiotics in dysbiosis, there are many immunological implications on GALT (Gut Associated Lymphoid Tissue).
Keywords :Halitosis; Kluyveromyces Marxianus B0399; Probiotic; Probiotic Lactic Yeast; Biosympa®
Abbreviations : VSC: Volatile Sulphur Compounds; GALT: Gut Associated Lymphoid Tissue; WHO: World Health Organization; SCFAs: Short-Chain Fatty AcidsIntroduction| Material and Methods| Discussion| Results| References|